Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …
Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …
GlaxoSmithKline has signed a major deal with Amgen to co-market its new osteoporosis treatment denosumab in Europe, Australia, New Zealand …
GlaxoSmithKline and Oxford-based Chroma Therapeutics are linking up to identify small molecule therapeutics in a bid to combat conditions like …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

